Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Cardiology in Review|December 28, 2022
Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-AnalysisJayakumar Sreenivasan, Aaqib Malik, Muhammad Shahzeb Khan, et al.
Journal of the American College of Cardiology|June 21, 2023
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient PopulationsMuhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D Anker, et al.
European Heart Journal|January 9, 2021
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trialJaved Butler, Stefan D Anker, Gerasimos Filippatos, et al.
Circulation. Cardiovascular Imaging|February 20, 2024
Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal StudyHooman Fazlalizadeh, Muhammad Shahzeb Khan, Ervin R Fox, et al.
Open Heart|February 11, 2021
Coronary artery aneurysms: outcomes following medical, percutaneous interventional and surgical managementShameer Khubber, Rajdeep Chana, Chandramohan Meenakshisundaram, et al.
Circulation|November 11, 2020
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced TrialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|May 29, 2020
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of CardiologyYuhui Zhang, Andrew J S Coats, Zhe Zheng, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
European Heart Journal|April 26, 2023
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trialsMuhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M Talha, et al.
Pageof 38